Small Caps
Ashley House crumbles as lower revenues fuel profit warning
Care home developer and operator Ashley House took a dive on Thursday after it warned that profits are now expected to fall short of market expectations as interim revenues dropped.
Stock Spirits grabs grappa distiller
Vodka distiller Stock Spirits has acquired Italian grappa and sparkling wine maker Distillerie Franciacorta for up to €26. 5m, including adjoining land for the construction of a new production facility.
Cambridge Cognition soars on Indian software partnership
Cambridge Cognition leapt on Thursday after entering a partnership with a major pharmaceutical company to deliver online neurological testing to patients in India using its cloud-based CANTAB Connect platform.
eServGlobal wins two Middle Eastern contracts for €1m
eServGlobal on Thursday inked two new contracts for its flagship PayMobile solution with existing customers in the Middle East, representing a combined total value of approximately €1m.
ValiRx allowed patents for VAL401 in Russia and China
Clinical-stage biotechnology company ValiRx announced on Thursday that the patent offices of Russia and China had both granted a patent allowance for its pre-clinical therapeutic compound, VAL301, subject to payment of the relevant fees.
Billington Holdings ends year in line with forecasts
Structural steel and construction safety company Billington Holdings updated the market on Thursday, saying it anticipated that its results for the year ended 31 December would be in line with market expectations.
Collagen Solutions signs new license agreement in Indonesia
Collagen Solutions has entered into a new license and distribution agreement for ‘ChondroMimetic’ with an Indonesian partner, PT Rajawali Mutiara Sejahtera, it announced on Thursday.
IronRidge pleased with progress at Cape Coast Lithium
IronRidge Resources updated the market on its activities at the Cape Coast Lithium portfolio in Ghana, West Africa on Thursday, reporting that the 4,684m reverse circulation (RC) exploration and resource drilling was completed at the Abonko target and Ewoyaa Lithium Project.
YouGov expecting bumper year after first half
Research and data analytics company YouGov updated the market for the six months ending 31 January on Thursday, reporting that half-year trading was anticipated to be ahead of the board's targets.
Watchstone revenues slide as 'challenging' conditions persist
Technology solutions outfit Watchstone saw revenues fall back and profits stay flat in its last trading year as a result of "challenging" trading conditions and adverse movements in the Canadian dollar.
Belvoir Lettings updates on year of 'continued and encouraging' growth
British property franchiser Belvoir Lettings reported a year of "continued and encouraging growth" on Thursday, with both revenues and profits moving ahead.
Location Sciences's anti-fraud software garners US interest at CES
Location Sciences Group edged upward on Thursday after reporting that trading "remained strong" in December and has begun the current year in line with expectations.
Diversified Gas and Oil restates revised guidance following 'strong' Q4
Diversified Gas and Oil told investors on Thursday that trading in the final quarter of 2018 had "remained strong".
FireAngel swings to loss in year of 'significant disruption and distraction'
Home safety outfit FireAngel warned investors on Thursday that its full-year results would fall short of market expectations, swinging to an underlying loss of £2m from a £4. 7m underlying profit last time.
Keywords Studios revenues soar in year of 'continued growth'
Computer games industry services provider Keywords Studios reported a pre-close update on a year of acquisitive and organic growth on Thursday.
ReNeuron upbeat on data around ease of exosome manufacture
Cell-based therapeutics developer ReNeuron Group announced on Thursday that new data relating to the manufacturing scale-up of its GMP produced, CTX-derived exosomes was being presented at a US forum on the manufacture of cell and gene therapies.
Scancell shares slip as losses widen in first half
Cancer immunotherapies developer Scancell Holdings issued its interim results for the six months ended 31 October on Thursday, reporting a loss of £3. 24m, widening from £2. 02m year-on-year.
Deinove hands rights to NBTI programme back to Redx Pharma
Drug discovery and development company Redx Pharma announced on Thursday that Deinove had decided not to exercise its option for Redx's ‘Novel Bacterial Topoisomerase Inhibitor’ (NBTI) programme.
Flowtech Fluidpower sales and spending grows in fourth quarter
AIM-listed outfit Flowtech Fluidpower saw revenues move ahead in the year ended 31 December as a result of solid sales in the fourth quarter.
Staffline shares suspended after accounting allegations
Shares recruiter Staffline were suspended after the close of trading overnight after the company said it was delaying its annual results.